Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates - The Wall Street Journal

1. Covid-19 Antibody Drugs Are Challenged by Omicron, Preliminary Testing Indicates  The Wall Street Journal
2. Regeneron: Antibody cocktail is less effective against omicron  CNBC Television
3. Tests suggest Regeneron antibody treatment for COVID loses effectiveness against omicron variant: WSJ  MarketWatch
4. Regeneron says its COVID-19 drug could be less effective against Omicron  Reuters
5. Omicron: Regeneron says Covid drug could be less effective against new variant  Livemint
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/2ZBmLDe